The scientific abstracts from the 2024 NYC Neuromodulation Conference are now published in Brain Stimulation Journal. The published collection captures the breadth of work presented at the 2024 meeting, reflecting rapid advances across both noninvasive and invasive brain stimulation.
The abstracts span core themes in the field, including transcranial magnetic and electric stimulation, deep brain and vagus nerve stimulation, closed-loop paradigms, computational modeling, device engineering, and clinical trials. Together, they highlight progress on precision dosing, individualized targeting, biomarkers of response, and translation from laboratory to clinic—topics that drew significant attention during the conference.
Readers can browse the full table of contents on the Brain Stimulation Journal website.
The 2024 NYC Neuromodulation organizers thank all authors, reviewers, and attendees whose efforts made the 2024 program a success and are pleased to see the work reach a broader audience through this publication.
Read this next
What Silicon Valley needs to know about the brain, and what it doesn't - Part I
Silicon Valley wants to get inside your head - literally. While these projects adopt mixes of commercial stealth and elaborate publicity, and the breadth of applications spans the entire human condition, all these technologies take one of two product forms: Either as a chip implanted in your head transmitting to a computer or as a wearable cap transmitting to a computer.
Neuromodulation for COVID-19, Neuromodec update 10: Major steps forward
This is the 10th update from Neuromodec (August 7, 2023) on the use of Neuromodulation for COVID-19 as part of Neuromodec’s initiative to educate on and advance treatments.
Perspective by Dr. Kip Ludwig: What does the recent Neuralink FDA IDE really mean?
No matter what, getting an Investigational Device Designation (IDE) for a brain implant from the Food and Drug Administration (FDA) isn’t trivial...
